Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic in refractory primary Sjogren's syndrome
NL-OMON28051Active, not recruiting
- Sponsor
- Professor Dr. Markus Gaubitz Muenster University Clinic Albert Schweitzer Sreet 33 48129 Muenster Germany [email protected] Tel: +49-251-8357562
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mycophenolate sodium in Sjögren's syndrome (SS), sponsored by Professor Dr. Markus Gaubitz Muenster University Clinic Albert Schweitzer Sreet 33 48129 Muenster Germany [email protected] Tel: +49-251-8357562. Primary endpoints: Efficacy of mycophenolate sodium treatment, Schirmer's test and 5 more. Started Apr 2005; status: active, not recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
Sjögren's syndrome (SS)
Beyond the preview
Go deeper on NL-OMON28051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28051.